Hematology Oncology of Indiana

What Hematology Oncology of Indiana does

Hematology Oncology of Indiana is a community-based medical oncology and hematology practice headquartered in Indianapolis, Indiana. Founded in 1982 with 7 physicians organized across 6 locations in central Indiana, the practice serves patients with solid tumors, hematologic malignancies, and benign blood disorders across a regional catchment. Its clinical service line spans medical oncology, hematology, bispecific T-cell engager (BiTE) therapy, specialty infusion, in-house pathology, pharmacy, care coordination, clinical trial enrollment, telehealth visits, and patient financial counseling, positioning it as a vertically integrated community oncology platform rather than a single-modality clinic.

Since joining American Oncology Network (AON) in May 2019, the practice has operated within a larger oncology network that spans 21 states and includes 350+ providers, with access to 150+ active clinical trials. Brian Mulherin, MD, a designated Castle Connolly Top Doctor 2024, serves as Medical Director within the AON structure, lending clinical governance oversight across the network. The AON affiliation provides centralized back-office infrastructure, drug procurement economics, and clinical research administration that the practice could not sustain as an independent group.

The business model operates on a fee-for-service revenue base typical of US community oncology, including professional services billing for physician visits, buy-and-bill drug economics on infusion regimens, and ancillary revenue from in-house pharmacy, pathology, and laboratory services. Patient payors are predominantly commercial insurance and Medicare, with a participation footprint that relies on regional referral patterns from primary care and hospital systems. The practice is private, with AON acting as its parent network.

Name

Hematology Oncology of Indiana

Legal name

Hematology Oncology of Indiana

Website

https://hematologyoncologyin.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

Hematology Oncology of Indiana is a community-based medical oncology and hematology practice with 6 locations across central Indiana. It serves patients with cancer and blood disorders, delivering medical oncology, hematology, BiTE and infusion therapy, pharmacy, pathology, clinical trials, and telehealth services under an AON affiliation.

Ownership category

akta.pro rank

Product category

Community Oncology and Hematology Services

NAICS

Other Outpatient Care Centers (62149), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industries

Hematologic Oncology (Leukemia/Lymphoma/Myeloma) (HLAKAFAD), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Medical oncology services
• Hematology treatments
• Community cancer care
• Specialty infusion therapy
• Clinical trials oncology

Headquarters

HQ city

Indianapolis

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Services Revenue: Revenue generated from providing medical oncology and hematology services including chemotherapy, immunotherapy, targeted therapies, infusion therapies, pathology services, and clinical trials. Services are billed through insurance including Medicare and private payers.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Hematology Oncology of Indiana is a community-based medical oncology and hematology practice providing treatment for all types of cancer and blood disorders. Services span medical oncology (chemotherapy, immunotherapy, targeted therapies, oral chemotherapy), hematology, BiTE therapy, specialty infusion, in-house pathology, in-house specialty pharmacy, care coordination, clinical trials, telehealth, and financial counseling — delivered across six Indiana locations and through virtual visits.

Product overview

Hematology Oncology of Indiana is a community-based medical oncology and hematology practice offering a comprehensive suite of cancer and blood disorder services. The practice operates as a unified care platform combining Medical Oncology, Hematology, and BiTE Therapy as core treatment modalities, supported by integrated specialty services including Pathology (centralized in-house laboratory), Pharmacy (specialty oral oncolytic medications), Specialty Infusion Services, Care Coordination & Navigation with survivorship programs, Clinical Trials, Telehealth virtual visits, and Financial Support. Services are delivered across six locations in Indiana through a coordinated team approach.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Oncology Cancer treatment service using chemotherapy, biological agents, targeted therapies, immunotherapy, and oral chemotherapy medications for patients diagnosed with various cancers.
• Hematology Diagnosis and treatment of hematologic malignancies including lymphoma, leukemia, myelodysplastic syndromes, multiple myeloma, myeloproliferative syndromes, aplastic anemia, and autoimmune blood disorders.
• BiTE Therapy Bispecific antibody therapy that links T cells to cancer cells, enabling the immune system to recognize and attack cancer more efficiently. Used for blood cancers and certain solid tumor cancers including acute lymphoblastic leukemia, uveal melanoma, diffuse large B-cell lymphoma, follicular lymphoma, multiple myeloma, and extensive-stage small cell lung cancer.
• Specialty Infusion Services Infusion therapies for chronic diseases including anemia, Crohn's disease, multiple sclerosis, rheumatoid arthritis, and other conditions, with partnerships across rheumatology, allergy, dermatology, gastroenterology, neurology, and pulmonology specialties.
• Pathology Centralized in-house laboratory providing routine and specialized testing with state-of-the-art facility staffed by hematopathologists and surgical pathologists, integrated with daily patient care for superior turnaround times.
• Pharmacy In-house specialty pharmacy for oral oncolytic medications providing 24/7 oncology pharmacist support, insurance assistance, prior authorizations, prescription reminders, and FedEx delivery at no additional charge.
• Care Coordination & Navigation Comprehensive care management including symptom monitoring, medication education, nutritional guidance, barrier identification (transportation, financial), personalized care planning, survivorship care plans, and oncology dietitian services.
• Clinical Trials Access to approved and exploratory therapies through clinical trials, enabling patients to participate without long-distance travel, in partnership with Investigative Clinical Research of Indiana.
• Telehealth Virtual video visits via Doxy.me platform allowing patients to meet with physicians, practitioners, nurses, or dietitians from home or any private location.
• Financial Support Financial counseling to help navigate insurance coverage and connect with patient assistance programs, including non-medical expense grants up to $750 per calendar year through American Oncology Cares Foundation.

Quantifiable outcome

• Longer survival rates in community oncology settings: 48 months median survival for metastatic breast cancer vs 40 months benchmark; 15 months vs 13 months for metastatic NSCLC

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature4 records

Partnerships

One partnership is on record.

• American Oncology Network (AON)coreStrategic or Co-development Partner · 1 May 2019Hematology Oncology of Indiana joined American Oncology Network in May 2019. AON is an alliance of physicians and healthcare leaders ensuring the long-term success of community oncology. The partnership provides enhanced technology, expanded oral oncolytic outpatient pharmacy, enhanced care management services, and access to over 150 clinical trials. AON represents 350+ providers across 21 states.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• OneOncology: Physician-led community oncology network partnering with independent practices across multiple states. Offers a comparable technology, pharmacy, and clinical research platform, and competes directly with AON for high-quality community oncology practice partnerships.
• Tennessee Oncology: Mid-sized community oncology practice with multi-site Tennessee operations. Comparable in providing integrated medical oncology, hematology, infusion, specialty pharmacy, and clinical research through a regional physician-led model.
• Florida Cancer Specialists & Research Institute: Large community-based medical oncology and hematology practice with a multi-site Florida footprint. Provides a comparable full-service model including infusion, in-house pharmacy, pathology, and clinical trials under community-based delivery.
• American Oncology Network: HOI's parent partner network and the most direct structural peer. AON is a physician-led community oncology alliance operating across 21 states with 350+ providers and 150+ clinical trials, providing the same technology, pharmacy, and care management infrastructure that HOI relies on.

Broad incumbents

• Texas Oncology: Large community-based oncology practice affiliated with The US Oncology Network, operating more than 200 sites across Texas. Comparable in offering comprehensive medical oncology, hematology, radiation, and clinical trials at community scale.
• City of Hope: National cancer research and treatment system operating specialty oncology centers across multiple states. Provides a higher-acuity oncology delivery model with research integration that competes for complex cancer referrals in overlapping geographies.
• The US Oncology Network (McKesson): The largest US community oncology network, affiliated with McKesson. Operates a similar physician-partner model across multiple states offering practice management, drug distribution, and clinical trials, competing with AON for community oncology partnerships at national scale.
• Sarah Cannon (HCA Healthcare): HCA Healthcare's cancer institute providing oncology services across HCA's hospital network. Operates as a broader-incumbent competitor offering hospital-based oncology that competes with community practices for patient referrals and clinical trial enrollment.

Regional players

• Ascension St. Vincent (Indianapolis): Hospital system hosting HOI's St. Vincent Breast Center and Fishers locations. Competes for oncology referrals in metropolitan Indianapolis through hospital-affiliated oncology programs and integrated specialty services.
• Indiana University Health: Indiana's largest academic health system with the IU Health Simon Comprehensive Cancer Center. Competes for oncology referrals in Indianapolis and surrounding regions via hospital-based and academic specialty oncology services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/HematologyOncologyIN
• LinkedInlinkedin.com/company/american-oncology-network

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hematology Oncology of Indiana